Integration of genetics and MRD to define low risk patients with B-cell precursor acute lymphoblastic leukaemia with intermediate MRD levels at the end of induction
(2024) In Leukemia 38(9). p.2023-2026
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/d2af1f6f-8e34-44e4-bab9-e4d340b33a03
- author
- organization
- publishing date
- 2024-09
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Leukemia
- volume
- 38
- issue
- 9
- pages
- 4 pages
- publisher
- Nature Publishing Group
- external identifiers
-
- pmid:38965371
- scopus:85197502631
- ISSN
- 0887-6924
- DOI
- 10.1038/s41375-024-02329-0
- language
- English
- LU publication?
- yes
- id
- d2af1f6f-8e34-44e4-bab9-e4d340b33a03
- date added to LUP
- 2024-12-11 13:57:53
- date last changed
- 2025-06-26 06:31:56
@article{d2af1f6f-8e34-44e4-bab9-e4d340b33a03, author = {{Moorman, Anthony V. and Enshaei, Amir and Murdy, Daniel and Joy, Melvin and Boer, Judith M. and den Boer, Monique L. and Pieters, Rob and de Haas, Valerie and Horstmann, Martin A. and Escherich, Gabriele and Johansson, Bertil and Marquart, Hanne V. and Schmiegelow, Kjeld and Hancock, Jeremy and Moppett, John and Heyman, Mats}}, issn = {{0887-6924}}, language = {{eng}}, number = {{9}}, pages = {{2023--2026}}, publisher = {{Nature Publishing Group}}, series = {{Leukemia}}, title = {{Integration of genetics and MRD to define low risk patients with B-cell precursor acute lymphoblastic leukaemia with intermediate MRD levels at the end of induction}}, url = {{http://dx.doi.org/10.1038/s41375-024-02329-0}}, doi = {{10.1038/s41375-024-02329-0}}, volume = {{38}}, year = {{2024}}, }